HAEMOPHILIA: Post hoc analysis of the long-term response of patients with hemophilia A to fixed-dose prevention of N8-GP

Clotting factor concentrates used for prevention remains the key to the prevention and control of severe hemophilia A method of treatment of bleeding
.

Extended half-life (EHL) Recombinant factor VIII (FVIII) molecules have lower injection frequency compared with standard half-life products, while maintaining a low annualized bleeding rate (ABR), thereby improving the quality of life

Clotting factor concentrates used for prevention remains the key to the prevention and control of severe hemophilia A method of treatment of bleeding

The results of long-term efficacy and pharmacokinetic drug fixed dose N8-GP prevention of data from the Pathfinder severe hemophilia A Pathfinder 2 and 5 tests were descriptive analysis

The results showed that during Pathfinder 2, 117/136 patients with study drug exposure ≥600 days had bleeding events; 8.

6% of bleeding was repeated bleeding; and the bleeding recurrence rate decreased over time

Original source:

Original source: Original source:

Tiede, A ,Hampton, K ,Jiménez-of Yuste, V , et Al.

Post-hoc Analysis ON The Long-Term Response to Fixed-dose prophylaxis with N8-the GP in patients with Haemophilia A .
Haemophilia .
2021 ;00.
1 -.
8 .

Tiede, A ,  Hampton, K ,  Jiménez-of Yuste, V , et Al.
  Post-hoc Analysis ON The Long-Term Response to Fixed-dose prophylaxis with N8-the GP in patients with Haemophilia A .
  Haemophilia .
  2021 ;  00  .
1 -  .
8 .
  https://doi.
org/10.
1111/hae.
14409 Tiede, A ,  Hampton, K ,  Jiménez-Yuste, V , et al.
  Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP patients with Haemophilia A in .
  Haemophilia .
  2021 ;  00  1 -  8.
  https://doi.
org/10.
1111/hae.
14409 Tiede, A Hampton, K Jiménez-Yuste, V Post-hoc analysis on the long-term response to fixed-dose prophylaxis with N8-GP in patients with haemophilia A Haemophilia 2021 00 1 8 https://doi.
org/10.
1111/hae.
14409 Leave a message here